Document Detail

Rituximab induces resolution of recurrent diffuse alveolar haemorrhage in a patient with primary antiphospholipid antibody syndrome.
MedLine Citation:
PMID:  21993385     Owner:  NLM     Status:  Publisher    
Diffuse alveolar hemorrhage (DAH) is a rare manifestation of primary antiphospholipid antibody syndrome (APS). We describe a patient with primary APS and refractory recurrent episodes of DAH. The patient was admitted 15 times due to recurrent episodes of DAH in a period of 18 months. Multiple immunosuppressive drugs did not improve his condition. Two years after his presentation, he was treated with rituximab (two doses of 1 g, 2 weeks apart). Six months later, the attacks of DAH have gradually disappeared. In a follow-up of more than 2 years after he received rituximab, the patient has had no further admissions due to DAH. Levels of antiphospholipid antibodies were measured during follow-up of 4 years. Anti-β2 glycoprotein IgG titer decreased to normal 6 months after therapy but anticardiolipin (aCL) antibody titer increased. We conclude that rituximab caused a dramatic clinical response in this patient. Anti-β2 glycoprotein IgG correlated better with the clinical response in this patient than aCL.
A S Elazary; P P Klahr; A Y Hershko; Z Dranitzki; A Rubinow; Y Naparstek
Related Documents :
25381645 - Electrophysiological study 6 months after epicor(™) high-intensity focused ultrasoun...
21816315 - Baroreflex activation therapy lowers blood pressure in patients with resistant hyperten...
25261425 - Effects of neuromuscular electrical stimulation and low-level laser therapy on the musc...
25474455 - Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treat...
22403415 - Wedge meatoplasty as a treatment for stricture of the urethral meatus in a cat.
18560215 - Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-12
Journal Detail:
Title:  Lupus     Volume:  -     ISSN:  1477-0962     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204265     Medline TA:  Lupus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a co...
Next Document:  A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosu...